Skip to main content
Top
Published in: Journal of Radiation Oncology 3/2014

01-09-2014 | Original Research

A novel 2D/3D transformation for radiosurgery of ocular tumors: computer simulation and phantom validation

Published in: Journal of Radiation Oncology | Issue 3/2014

Login to get access

Abstract

Objective

Noninvasive stereotactic radiosurgery with the Cyberknife system has been seen as a promising treatment platform for ocular tumors in clinical practice. However, due to the unpredictable eye movement during treatment, 6D skull tracking cannot account for random ocular tumor positions and therefore compromise treatment delivery precision. A real-time ocular tumor tracking system is highly desirable.

Methods

We designed a novel “pupil tracking” approach that uses a derived 2D/3D transformation to relate the pupil’s 2D coordinate captured by a video camera in the image plane with the tumor’s 3D location in the CT space. To simulate and demonstrate the process of the 2D/3D transformation, a computer graphical model was created by using an interactive interface to mimic both tumor (size and location inside the eyeball) and eyeball (movement parameters). A mechanical phantom was also fabricated to validate the approach.

Results

Experimental data from computer simulation and phantom validation under the CT simulator were obtained. For eight testing points in the validation experiment by the mechanical phantom, the maximum root-sum-squared error (RSSE) of three coordinates (X, Y, Z) is less than 0.70 mm and the mean-squared error is 0.44 mm.

Conclusion

Error analysis indicates that this pupil tracking technique has a potential application for radiosurgery of ocular tumors by the Cyberknife system.
Appendix
Available only for authorised users
Literature
1.
go back to reference Carvounis PE, Katz B (2003) Gamma knife radiosurgery in neuro-ophthalmology. Curr Opin Ophthalmol 14(6):317–24PubMedCrossRef Carvounis PE, Katz B (2003) Gamma knife radiosurgery in neuro-ophthalmology. Curr Opin Ophthalmol 14(6):317–24PubMedCrossRef
2.
go back to reference Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83(8):1664–78PubMedCrossRef Chang AE, Karnell LH, Menck HR (1998) The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 83(8):1664–78PubMedCrossRef
3.
go back to reference Chauvel P, Iborra-Brassart N, Courdi A, Hérault J, Teissier E, Pignol JP, Bondiau PY (1996) Proton therapy in ophthalmology: status report and problems encountered. Bull Cancer Radiother 83:215 s–8 sCrossRef Chauvel P, Iborra-Brassart N, Courdi A, Hérault J, Teissier E, Pignol JP, Bondiau PY (1996) Proton therapy in ophthalmology: status report and problems encountered. Bull Cancer Radiother 83:215 s–8 sCrossRef
4.
go back to reference Cheng B (2008) Saw. Implementation of fidutial-based image registration in the cyberknife robotic system. Med Dosim 33(2):156–160CrossRef Cheng B (2008) Saw. Implementation of fidutial-based image registration in the cyberknife robotic system. Med Dosim 33(2):156–160CrossRef
5.
go back to reference Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD (2005) Proton beam radiotherapy of choroidal melanoma: the Liverpool–Clatterbridge experience. Int J Radiat Oncol Biol Phys 62(5):1405–11PubMedCrossRef Damato B, Kacperek A, Chopra M, Campbell IR, Errington RD (2005) Proton beam radiotherapy of choroidal melanoma: the Liverpool–Clatterbridge experience. Int J Radiat Oncol Biol Phys 62(5):1405–11PubMedCrossRef
6.
go back to reference Dutton JJ, Aderson RL, Schelper RL, Purcell JJ, Tse DT (1984) Orbital malignant melanoma and oculodemal melanocytosis: report of two cases and review of the literature. Ophthalmology 91(5):497–507PubMedCrossRef Dutton JJ, Aderson RL, Schelper RL, Purcell JJ, Tse DT (1984) Orbital malignant melanoma and oculodemal melanocytosis: report of two cases and review of the literature. Ophthalmology 91(5):497–507PubMedCrossRef
7.
go back to reference Emara K, Weisbrod DJ, Sahgal A, McGowan H, Jaywant S, Michaels H, Payne D, Pintilie M, Laperriere NJ, Simpson ER (2004) Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: preliminary results. Int J Radiat Oncol Biol Phys 59(1):94–100PubMedCrossRef Emara K, Weisbrod DJ, Sahgal A, McGowan H, Jaywant S, Michaels H, Payne D, Pintilie M, Laperriere NJ, Simpson ER (2004) Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: preliminary results. Int J Radiat Oncol Biol Phys 59(1):94–100PubMedCrossRef
8.
go back to reference Fürweger C, Drexler C, Kufeld M, Muacevic A, Wowra B, Schlaefer A (2010) Patient motion and targeting accuracy in robotic spinal radiosurgery: 260 single-fraction fiducial-free cases. Int J Radiat Oncol Biol Phys 78(3):937–45PubMedCrossRef Fürweger C, Drexler C, Kufeld M, Muacevic A, Wowra B, Schlaefer A (2010) Patient motion and targeting accuracy in robotic spinal radiosurgery: 260 single-fraction fiducial-free cases. Int J Radiat Oncol Biol Phys 78(3):937–45PubMedCrossRef
9.
10.
go back to reference Harbour JW, Murray TG, Byrne SF, Hughes JR, Gendron EK, Ehlies FJ, Markoe AM (1996) Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina 16(2):129–34PubMedCrossRef Harbour JW, Murray TG, Byrne SF, Hughes JR, Gendron EK, Ehlies FJ, Markoe AM (1996) Intraoperative echographic localization of iodine 125 episcleral radioactive plaques for posterior uveal melanoma. Retina 16(2):129–34PubMedCrossRef
11.
go back to reference Hérault J, Iborra N, Serrano B, Chauvel P (2005) Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma. Med Phys 32(4):910–9PubMedCrossRef Hérault J, Iborra N, Serrano B, Chauvel P (2005) Monte Carlo simulation of a protontherapy platform devoted to ocular melanoma. Med Phys 32(4):910–9PubMedCrossRef
12.
go back to reference Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, Diddie KR, Engstrom RE Jr, Finger PT, Hovland KR, Joffe L, Olsen KR, Wells CG (2002) Collaborative Ocular Melanoma Study Group (COMS Group). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 109(12):2197–206PubMedCrossRef Jampol LM, Moy CS, Murray TG, Reynolds SM, Albert DM, Schachat AP, Diddie KR, Engstrom RE Jr, Finger PT, Hovland KR, Joffe L, Olsen KR, Wells CG (2002) Collaborative Ocular Melanoma Study Group (COMS Group). The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology 109(12):2197–206PubMedCrossRef
13.
go back to reference Jaywant SM, Osei EK, Ladak S (2003) Stereotactic radiotherapy in the treatment of ocular melanoma: a noninvasive eye fixation aid and tracking system. J Appl Clin Med Phys 4(2):156–161PubMedCrossRef Jaywant SM, Osei EK, Ladak S (2003) Stereotactic radiotherapy in the treatment of ocular melanoma: a noninvasive eye fixation aid and tracking system. J Appl Clin Med Phys 4(2):156–161PubMedCrossRef
14.
go back to reference Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe’er J (2009) Ruthernium-106 plaque brachytherapy for thick posterior uveal melanomas. Br J Ophthalmol 93(9):1167–1171PubMedCrossRef Kaiserman N, Kaiserman I, Hendler K, Frenkel S, Pe’er J (2009) Ruthernium-106 plaque brachytherapy for thick posterior uveal melanomas. Br J Ophthalmol 93(9):1167–1171PubMedCrossRef
15.
go back to reference Liscák R, Vladyka V (2007) Radiosurgery in ocular disorders: clinical applications. Prog Neurol Surg 20:324–39PubMed Liscák R, Vladyka V (2007) Radiosurgery in ocular disorders: clinical applications. Prog Neurol Surg 20:324–39PubMed
16.
go back to reference Marchini G, Babighian S, Tomazzoli L, Gerosa MA, Nicolato A, Bricolo A, Piovan E, Zampieri PG, Alessandrini F, Benati A et al (1995) Stereotactic radiosurgery of uveal melanomas: preliminary results with Gamma Knife treatment. Stereotact Funct Neurosurg 64(Suppl 1):72–9PubMed Marchini G, Babighian S, Tomazzoli L, Gerosa MA, Nicolato A, Bricolo A, Piovan E, Zampieri PG, Alessandrini F, Benati A et al (1995) Stereotactic radiosurgery of uveal melanomas: preliminary results with Gamma Knife treatment. Stereotact Funct Neurosurg 64(Suppl 1):72–9PubMed
17.
go back to reference McCartney ACE (1995) Pathology of ocular melanomas. Br Med Bull 51(3):678–693PubMed McCartney ACE (1995) Pathology of ocular melanomas. Br Med Bull 51(3):678–693PubMed
18.
go back to reference Michalec B, Swakoń J, Sowa U, Ptaszkiewicz M, Cywicka-Jakiel T, Olko P (2010) Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland. Appl Radiat Isot 68(4–5):738–42PubMedCrossRef Michalec B, Swakoń J, Sowa U, Ptaszkiewicz M, Cywicka-Jakiel T, Olko P (2010) Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland. Appl Radiat Isot 68(4–5):738–42PubMedCrossRef
19.
go back to reference Miralbell R, Caro M, Weber DC, Elizalde J, Perez-Ochoa A, Villà S, IgnacioToscas J, Martinez P, Linero D, Nouet P, Escudé L (2007) Stereotactic radiotherapy for ocular melanoma: initial experience using closed eyes for ocular target immobilization. Technol Cancer Res Treat 6(5):413–7PubMed Miralbell R, Caro M, Weber DC, Elizalde J, Perez-Ochoa A, Villà S, IgnacioToscas J, Martinez P, Linero D, Nouet P, Escudé L (2007) Stereotactic radiotherapy for ocular melanoma: initial experience using closed eyes for ocular target immobilization. Technol Cancer Res Treat 6(5):413–7PubMed
20.
go back to reference Mukhopadhyay J, Bhowmick P, Das PP. Digital geometry in image processing. CRC Press, 2013 Mukhopadhyay J, Bhowmick P, Das PP. Digital geometry in image processing. CRC Press, 2013
21.
go back to reference Papastefanou VP, Cohen VML. Uveal melanoma. J Skin Cancer, 2011; article ID 573974 Papastefanou VP, Cohen VML. Uveal melanoma. J Skin Cancer, 2011; article ID 573974
22.
go back to reference Robertson DM, Earle JD, Kline RW. Brachytherapy for choroidal melanoma. In The retina, S.J. Ryan, Ed., pp. 747–759, Elsevier-Mosby, 4th edition, 2006 Robertson DM, Earle JD, Kline RW. Brachytherapy for choroidal melanoma. In The retina, S.J. Ryan, Ed., pp. 747–759, Elsevier-Mosby, 4th edition, 2006
23.
go back to reference Singh AD, Topham A (2003) Incidence of ueval melanoma in the United States: 1973–1997. Ophthalmology 110(5):956–61PubMedCrossRef Singh AD, Topham A (2003) Incidence of ueval melanoma in the United States: 1973–1997. Ophthalmology 110(5):956–61PubMedCrossRef
24.
go back to reference Snell RS, Lemp MA. Clinical anatomy of the eye. Blackwell Science, Inc. 2nd Edition, 1998 Snell RS, Lemp MA. Clinical anatomy of the eye. Blackwell Science, Inc. 2nd Edition, 1998
25.
go back to reference Stahl JS, Alphen AM, Zeeuw CI (2009) A comparison of video and magnetic search coil recordings of mouse eye movements. J Neurosci Methods 99:101–110CrossRef Stahl JS, Alphen AM, Zeeuw CI (2009) A comparison of video and magnetic search coil recordings of mouse eye movements. J Neurosci Methods 99:101–110CrossRef
26.
go back to reference Strickland D, Lee JA (1981) Melanomas of eye: stability of rates. Am J Epidemiol 113(6):700–2PubMed Strickland D, Lee JA (1981) Melanomas of eye: stability of rates. Am J Epidemiol 113(6):700–2PubMed
27.
go back to reference Woodburn R, Danis R, Timmerman R, Witt T, Ciulla T, Worth R, Bank M, Coffman S (2000) Preliminary experience in the treatment of choroidal melanoma with gamma knife radiosurgery. J Neurosurg 93(Suppl 3):177–9PubMed Woodburn R, Danis R, Timmerman R, Witt T, Ciulla T, Worth R, Bank M, Coffman S (2000) Preliminary experience in the treatment of choroidal melanoma with gamma knife radiosurgery. J Neurosurg 93(Suppl 3):177–9PubMed
28.
go back to reference Zehetmayer M, Dieckmann K, Kren G, Kitz K, Ruhswurm I, Georgopoulos M, Pötter R (1999) Fractionated stereotactic radiotherapy with linear accelerator for uveal melanoma—preliminary Vienna results. Strahlenther Onkol 175(Suppl 2):74–5PubMedCrossRef Zehetmayer M, Dieckmann K, Kren G, Kitz K, Ruhswurm I, Georgopoulos M, Pötter R (1999) Fractionated stereotactic radiotherapy with linear accelerator for uveal melanoma—preliminary Vienna results. Strahlenther Onkol 175(Suppl 2):74–5PubMedCrossRef
29.
go back to reference Zorlu F, Selek U, Kiratli H (2009) Initial results of fractionated CyberKnife radiosurgery for uveal melanoma. J Neurooncol 94(1):111–7PubMedCrossRef Zorlu F, Selek U, Kiratli H (2009) Initial results of fractionated CyberKnife radiosurgery for uveal melanoma. J Neurooncol 94(1):111–7PubMedCrossRef
30.
go back to reference Zytkovicz A, Daftari I, Phillips TL, Chuang CF, Verhey L, Petti PL (2007) Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy. Phys Med Biol 52(19):5957–71PubMedCrossRef Zytkovicz A, Daftari I, Phillips TL, Chuang CF, Verhey L, Petti PL (2007) Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy. Phys Med Biol 52(19):5957–71PubMedCrossRef
Metadata
Title
A novel 2D/3D transformation for radiosurgery of ocular tumors: computer simulation and phantom validation
Publication date
01-09-2014
Published in
Journal of Radiation Oncology / Issue 3/2014
Print ISSN: 1948-7894
Electronic ISSN: 1948-7908
DOI
https://doi.org/10.1007/s13566-013-0139-y

Other articles of this Issue 3/2014

Journal of Radiation Oncology 3/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine